Gradient Investments’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-450
| Closed | -$40.2K | – | 1862 |
|
2023
Q4 | $40.2K | Sell |
450
-23
| -5% | -$2.05K | ﹤0.01% | 588 |
|
2023
Q3 | $34.5K | Hold |
473
| – | – | ﹤0.01% | 584 |
|
2023
Q2 | $39.4K | Sell |
473
-200
| -30% | -$16.6K | ﹤0.01% | 551 |
|
2023
Q1 | $51.3K | Hold |
673
| – | – | ﹤0.01% | 492 |
|
2022
Q4 | $55.9K | Hold |
673
| – | – | ﹤0.01% | 479 |
|
2022
Q3 | $53K | Buy |
673
+23
| +4% | +$1.81K | ﹤0.01% | 476 |
|
2022
Q2 | $48K | Hold |
650
| – | – | ﹤0.01% | 483 |
|
2022
Q1 | $58K | Hold |
650
| – | – | ﹤0.01% | 450 |
|
2021
Q4 | $73K | Hold |
650
| – | – | ﹤0.01% | 414 |
|
2021
Q3 | $82K | Hold |
650
| – | – | ﹤0.01% | 400 |
|
2021
Q2 | $88K | Sell |
650
-150
| -19% | -$20.3K | ﹤0.01% | 385 |
|
2021
Q1 | $109K | Hold |
800
| – | – | ﹤0.01% | 353 |
|
2020
Q4 | $89K | Hold |
800
| – | – | ﹤0.01% | 329 |
|
2020
Q3 | $89K | Hold |
800
| – | – | ﹤0.01% | 330 |
|
2020
Q2 | $90K | Buy |
800
+199
| +33% | +$22.4K | ﹤0.01% | 313 |
|
2020
Q1 | $47K | Buy |
601
+301
| +100% | +$23.5K | ﹤0.01% | 357 |
|
2019
Q4 | $29K | Hold |
300
| – | – | ﹤0.01% | 507 |
|
2019
Q3 | $23K | Hold |
300
| – | – | ﹤0.01% | 511 |
|
2019
Q2 | $26K | Hold |
300
| – | – | ﹤0.01% | 476 |
|
2019
Q1 | $27K | Buy |
+300
| New | +$27K | ﹤0.01% | 410 |
|
2018
Q2 | – | Sell |
-188
| Closed | -$16K | – | 1156 |
|
2018
Q1 | $16K | Sell |
188
-2,500
| -93% | -$213K | ﹤0.01% | 533 |
|
2017
Q4 | $228K | Buy |
+2,688
| New | +$228K | 0.01% | 239 |
|
2017
Q3 | – | Sell |
-11,700
| Closed | -$903K | – | 727 |
|
2017
Q2 | $903K | Sell |
11,700
-1,519
| -11% | -$117K | 0.06% | 99 |
|
2017
Q1 | $917K | Sell |
13,219
-1,081
| -8% | -$75K | 0.07% | 104 |
|
2016
Q4 | $846K | Buy |
+14,300
| New | +$846K | 0.07% | 104 |
|